Deciphering the mechanism of action of VP343, an antileishmanial drug candidate, in Leishmania infantum
Summary: Antileishmanial chemotherapy is currently limited due to severe toxic side effects and drug resistance. Hence, new antileishmanial compounds based on alternative approaches, mainly to avoid the emergence of drug resistance, are needed. The present work aims to decipher the mechanism of acti...
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Elsevier
2023-11-01
|
| Col·lecció: | iScience |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2589004223022216 |